Literature DB >> 10769164

The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20.

A Couvineau1, J J Maoret, C Rouyer-Fessard, I Carrero, M Laburthe.   

Abstract

The basic organization of the human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor (VPAC) 1 promoter was investigated after cloning the 5'-flanking region (1.4 kb) of the VPAC1 gene from a human genomic library. Subsequent functional analysis of various deletions of the 5'-flanking sequence, subcloned upstream of a luciferase reporter gene, was carried out in HT-29 cells. The minimal promoter region identified encompasses the -205/+76 sequence and contains a crucial CCAAT box (-182/-178) and a GC-rich sequence. Moreover a region (-1348/-933) containing a silencer element was identified. We previously showed that the expression of the VPAC1 receptor binding site is strictly dependent upon the enterocytic differentiation of human colon cancer Caco-2 cells [Laburthe, Rousset, Rouyer-Fessard, Couvineau, Chantret, Chevalier and Zweibaum (1987) J. Biol. Chem. 262, 10180-10184]. In the present study we show that VPAC1 mRNA increases dramatically when Caco-2Cl.20 cells differentiate, as measured by RNase protection assays and reverse transcriptase-PCR. A single transcript species of 3 kb is detected in differentiated cells by Northern-blot analysis. Accumulation of VPAC1 receptor mRNA is due to a 5-fold increase of transcription rate (run-on assay) without a change in mRNA half-life (9 h). Stable transfections of various constructs in Caco-2Cl.20 cells and subsequent analysis of reporter gene expression, during the enterocytic differentiation process over 25 days of culture, further indicated that the -254/+76 5'-flanking sequence is endowed with the regulatory element(s) necessary for transcriptional regulation of VPAC1 during differentiation. Altogether, these observations provide the first characterization of the basic organization of the human VPAC1 gene promoter and unravel the crucial role of a short promoter sequence in the strict transcriptional control of VPAC1 expression during differentiation of human colon cancer Caco-2 cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10769164      PMCID: PMC1220997     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Molecular cloning of a novel transcriptional repressor protein of the rat type 1 vasoactive intestinal peptide receptor gene.

Authors:  L Pei
Journal:  J Biol Chem       Date:  1998-07-31       Impact factor: 5.157

2.  Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship.

Authors:  P Nicole; K Du; A Couvineau; M Laburthe
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

Review 3.  Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors.

Authors:  C D Ulrich; M Holtmann; L J Miller
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

4.  alpha-Latrotoxin stimulates exocytosis by the interaction with a neuronal G-protein-coupled receptor.

Authors:  V G Krasnoperov; M A Bittner; R Beavis; Y Kuang; K V Salnikow; O G Chepurny; A R Little; A N Plotnikov; D Wu; R W Holz; A G Petrenko
Journal:  Neuron       Date:  1997-06       Impact factor: 17.173

5.  Chimaeric VIP2/PACAP receptors reveal that agonist pharmacology but not signal transduction is determined by extracellular domain 1.

Authors:  E M Lutz; C J MacKenzie; J Morrow; R Mitchell; J Bennie; S Carroll; E Clark; A J Harmar
Journal:  Ann N Y Acad Sci       Date:  1996-12-26       Impact factor: 5.691

6.  Constitutive activation of the human vasoactive intestinal peptide 1 receptor, a member of the new class II family of G protein-coupled receptors.

Authors:  P Gaudin; J J Maoret; A Couvineau; C Rouyer-Fessard; M Laburthe
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

7.  Retinoic acid down-regulates the expression of the vasoactive intestinal polypeptide receptor type-1 in human breast carcinoma cell lines.

Authors:  B Madsen; B Georg; H Vissing; J Fahrenkrug
Journal:  Cancer Res       Date:  1998-11-01       Impact factor: 12.701

8.  Cloning and characterization of the 5'-flanking region of the human growth hormone secretagogue receptor gene.

Authors:  H Kaji; S Tai; Y Okimura; G Iguchi; Y Takahashi; H Abe; K Chihara
Journal:  J Biol Chem       Date:  1998-12-18       Impact factor: 5.157

9.  The human vasoactive intestinal Peptide/Pituitary adenylate cyclase activating peptide receptor 1 (VPAC1): constitutive activation by mutations at threonine 343.

Authors:  P Gaudin; A Couvineau; C Rouyer-Fessard; J J Maoret; M Laburthe
Journal:  Biochem Biophys Res Commun       Date:  1999-01-08       Impact factor: 3.575

Review 10.  International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.

Authors:  A J Harmar; A Arimura; I Gozes; L Journot; M Laburthe; J R Pisegna; S R Rawlings; P Robberecht; S I Said; S P Sreedharan; S A Wank; J A Waschek
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.